Robert P Schleimer Selected Research

Communicable Diseases (Infectious Diseases)

1/2018	Pathogenic and protective roles of B cells and antibodies in patients with chronic rhinosinusitis.
3/2010	Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis.
1/2005	Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert P Schleimer Research Topics

Disease

62	Rhinosinusitis 12/2023 - 12/2004
60	Nasal Polyps (Nasal Polyp) 12/2023 - 06/2008
40	Inflammation (Inflammations) 12/2023 - 01/2002
34	Asthma (Bronchial Asthma) 01/2022 - 01/2002
13	Polyps 12/2023 - 03/2006
8	Infections 01/2021 - 01/2005
6	Virus Diseases (Viral Diseases) 01/2021 - 07/2007
5	Hypersensitivity (Allergy) 01/2022 - 05/2009
4	Edema (Dropsy) 01/2023 - 01/2013
4	Eosinophilia 11/2017 - 01/2009
4	type 2C Congenital disorder of glycosylation 01/2015 - 03/2008
3	Fibrosis (Cirrhosis) 01/2023 - 04/2014
3	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2005
3	Airway Remodeling 04/2015 - 06/2012
2	Bronchiectasis 01/2022 - 12/2019
2	Pneumonia (Pneumonitis) 01/2021 - 07/2017
2	Anosmia 11/2019 - 07/2016
2	Food Hypersensitivity (Food Allergy) 01/2019 - 01/2009
2	Allergic Rhinitis 01/2017 - 01/2016
2	Gastroesophageal Reflux (GERD) 01/2016 - 05/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2015 - 01/2005
2	Respiratory Hypersensitivity 04/2014 - 06/2012
2	Hyperplasia 04/2014 - 06/2012
2	Anaphylaxis (Anaphylactic Shock) 01/2013 - 01/2009
2	Necrosis 10/2010 - 03/2008
1	Tertiary Lymphoid Structures 12/2023

Drug/Important Bio-Agent (IBA)

16	CytokinesIBA 12/2023 - 01/2004
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
15	Messenger RNA (mRNA)IBA 01/2022 - 11/2004
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 07/2011
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2012
10	AntibodiesIBA 01/2022 - 12/2011
9	FibrinIBA 11/2022 - 01/2013
9	Immunoglobulin E (IgE)IBA 01/2021 - 09/2008
9	AllergensIBA 01/2019 - 09/2008
8	ChemokinesIBA 01/2013 - 01/2004
7	Interleukin-13IBA 12/2023 - 08/2008
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2003
7	GlucocorticoidsIBA 01/2017 - 01/2002
6	Thymic Stromal LymphopoietinIBA 01/2023 - 07/2007
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2008
6	LigandsIBA 01/2017 - 07/2010
5	Immunoglobulin G (IgG)IBA 01/2022 - 09/2008
5	Complement System Proteins (Complement)IBA 01/2021 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2009
5	EnzymesIBA 11/2017 - 01/2004
4	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 06/2008
4	Interleukin-4 (Interleukin 4)IBA 01/2023 - 03/2008
4	Plasminogen Activators (Plasminogen Activator)IBA 11/2022 - 06/2012
4	Interleukin-5 (Interleukin 5)IBA 11/2022 - 01/2017
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2013
4	AutoantibodiesIBA 01/2022 - 12/2011
4	Cyclooxygenase 1IBA 01/2021 - 07/2017
4	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2010 - 12/2004
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023 - 03/2015
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2010
3	Pattern Recognition ReceptorsIBA 01/2021 - 01/2006
3	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2013
3	ImmunosorbentsIBA 11/2017 - 10/2010
3	LipopolysaccharidesIBA 01/2017 - 07/2010
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2014 - 01/2002
3	AntigensIBA 04/2013 - 04/2005
2	PeriostinIBA 12/2023 - 12/2015
2	Oncostatin MIBA 01/2023 - 06/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	CollagenIBA 01/2023 - 06/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022 - 01/2022
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 11/2022 - 01/2002
2	Eosinophil Cationic ProteinIBA 01/2022 - 11/2017
2	OvalbuminIBA 01/2022 - 01/2016
2	ORALIT (ORS)IBA 01/2022 - 01/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2020
2	Tryptases (Tryptase)IBA 01/2020 - 08/2012
2	Chemokine CCL26IBA 01/2017 - 11/2004
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 02/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2015
2	Enterotoxins (Enterotoxin)IBA 01/2016 - 01/2009
2	S100 Proteins (S 100 Protein)IBA 11/2015 - 03/2010
2	Factor XIII (Coagulation Factor XIII)IBA 09/2015 - 09/2013
2	Plasminogen Activator Inhibitor 1IBA 01/2015 - 06/2012
2	Substance PIBA 01/2014 - 10/2010
2	Interleukin-1 (Interleukin 1)IBA 07/2012 - 07/2011
2	B-Cell Activating FactorIBA 12/2011 - 06/2008
2	Immunoglobulin A (IgA)IBA 12/2011 - 06/2008
2	InterleukinsIBA 10/2010 - 07/2010
2	NeuropeptidesIBA 10/2010 - 03/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 07/2007
2	LuciferasesIBA 07/2010 - 11/2004
2	Interleukin-10 (Interleukin 10)IBA 07/2010 - 01/2002
2	Chemokine CCL5IBA 01/2010 - 07/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2008 - 07/2007
2	Collectins (Collectin)IBA 07/2007 - 01/2005
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2006 - 01/2006
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2023
1	Vitamin D FDA LinkGeneric 12/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	SubtilisinIBA 01/2023
1	betaglycan (TGFBR3)IBA 01/2023

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2002